Viewing StudyNCT01561794



Ignite Creation Date: 2024-05-06 @ 12:24 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01561794
Status: COMPLETED
Last Update Posted: 2015-04-27
First Post: 2012-03-21

Brief Title: A Phase III Study to Evaluate the Safety Efficacy and PharmacokineticsPharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Sponsor: Bayer
Organization: Bayer

Conditions & Keywords Data

Conditions:
Name
Pneumonia
Keywords:
Name View
400 mg BIDTID View
Ciprofloxacin View
Bacterial pneumonia View
Community Acquired Pneumonia CAP View
Hospital Acquired Pneumonia HAP View
Secondary infection of chronic respiratory disease View